➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 10,143,755

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,143,755
Title:Anhydrous hydrogel composition and delivery system
Abstract: The present disclosure relates to anhydrous hydrogels useful as mucoadhesive (oral compositions) or as topical agents and may be used to deliver an active agent such as active pharmaceutical agents (API\'s), coagulants, fragrances, flavors, and other actives and excipients.
Inventor(s): Borja; John (Keyport, NJ), Hayano; Stephanie Sharon (Millerton, NY)
Assignee: Acupac Packaging Inc. (Mahwah, NJ)
Application Number:15/835,517
Patent Claims:see list of patent claims

Details for Patent 10,143,755

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew REGRANEX becaplermin GEL; TOPICAL 103691 1997-12-16 ⤷  Free Forever Trial Acupac Packaging Inc. (Mahwah, NJ) 2033-05-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,143,755

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2014186742 ⤷  Free Forever Trial
United States of America 2015017105 ⤷  Free Forever Trial
United States of America 2017239359 ⤷  Free Forever Trial
United States of America 2018099052 ⤷  Free Forever Trial
United States of America 2019060469 ⤷  Free Forever Trial
United States of America 9603934 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.